Thalidomide for the Treatment of Thrombocytopenia and Hypersplenism in Patients With Cirrhosis or Thalassemia
Hypersplenism and thrombocytopenia are common complications of liver cirrhosis or thalassemia, but current treatment strategies are limited. This study aimed to evaluate the efficacy and safety of thalidomide in the treatment of hypersplenism and thrombocytopenia in patients with liver cirrhosis or...
Saved in:
Main Authors: | Yaocheng Chen (Author), Ning Cai (Author), Yongrong Lai (Author), Weiwei Xu (Author), Jinyan Li (Author), Lan Huang (Author), Ying Huang (Author), Meiling Hu (Author), Huangju Yang (Author), Jiangming Chen (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigating the Efficacy and Safety of Thalidomide for Treating Patients With ß-Thalassemia: A Meta-Analysis
by: Yanfei Lu, et al.
Published: (2022) -
Magnetic Resonance Imaging Quantification of the Liver Iron Burden and Volume Changes Following Treatment With Thalidomide in Patients With Transfusion-Dependent ß-Thalassemia
by: Jinlian Che, et al.
Published: (2022) -
Clinical efficacy of thalidomide for various genotypes of beta thalassemia
by: Wei-jia Yang, et al.
Published: (2024) -
Management of hypersplenism in hemolytic anemias
by: Amita Mahajan
Published: (2024) -
Effects of Thalidomide on the Expression of Adhesion Molecules in Rat Liver Cirrhosis
Published: (2006)